Abstract |
Composite regulatory signature database ( CRSD), a self-developed comprehensive Web server for composite regulatory signature discovery, used to compare the published microarray data with our data on patients with uterine leiomyoma treated with or without GnRH analogue ( GnRH-a), revealed that the focal adhesion, mitogen-activated protein kinase (MAPK), CXC chemokine receptor 4/stromal-derived factor-1 (CXCR4/SDF-1), T-cell receptor, integrin, vascular endothelial growth factor ( VEGF), GnRH, and transforming growth factor-beta ( TGF-beta) signaling pathways are highly expressed in uterine leiomyoma and significantly down-regulated after GnRH-a treatment. According to the results these signaling pathways could be involved in inflammation, proliferation, and remodeling processes of leiomyoma development and possibly in the regression of leiomyoma after GnRH-a treatment, which might improve our understanding of the mechanisms of leiomyoma formation and help us to find novel drug targets or specific markers for diagnosis and prognosis in uterine leiomyoma.
|
Authors | Huei-Wen Chen, Jim C C Liu, Jeremy J W Chen, Yee-Ming Lee, Jiann-Loung Hwang, Chii-Ruey Tzeng |
Journal | Fertility and sterility
(Fertil Steril)
Vol. 90
Issue 4
Pg. 1219-25
(Oct 2008)
ISSN: 1556-5653 [Electronic] United States |
PMID | 18258233
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Neoplasm Proteins
- Gonadotropin-Releasing Hormone
|
Topics |
- Computer Simulation
- Female
- Gene Expression Regulation, Neoplastic
(drug effects)
- Gonadotropin-Releasing Hormone
(administration & dosage)
- Humans
- Leiomyoma
(metabolism)
- Models, Biological
- Neoplasm Proteins
(metabolism)
- Signal Transduction
(drug effects)
- Tumor Cells, Cultured
- Uterine Neoplasms
(metabolism)
|